News & Events

Xplico participates in international congresses and events 6-8 times a year in Europe and the US, so there are plenty of opportunities to meet up with us.

We would be delighted to give you a presentation of our products and services and/or to discuss your specific needs, so please do not hesitate to book a meeting, either during a conference or at a time convenient for you, to discuss how you can benefit from our valuation and consulting services.

BioPharm America, Raleigh, USA, 13-14 September 2023.

BioPharm America attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts and it’s the perfect opportunity to engage with global life science partners. BioPharm America is where biotech industry partnerships get started.

The conference takes place in Raleigh, North Carolina, US, on September 13-14 for meetings in person and virtually on September 19-20.

(June 2023)

LSX Nordic Congress, Copenhagen, Denmark, 10-11 October 2023.

The LSX Nordic Congress is the leading senior executive strategy, investment and partnering conference for the Nordic region. It has been connecting life science and healthcare industry leaders with international investment and strategic partners to further the growth, development and internationalization of Nordic life science and healthcare innovation since 2018. The mission is to facilitate ever greater international investment into the region, as well as foster strategic partnerships and collaboration with key international healthcare stakeholders.

The LSX Nordic Congress is scheduled to take place in Copenhagen, Denmark, on October 10-11.

(June 2023)

BIO-Europe, Munich, Germany, 6-8 November 2023.

BIO-Europe is the gateway to the global biopharma community. The conference convenes over 5,000 attendees, representing 60 countries and 2,220+ companies, making the event the industry's largest gathering of biopharma professionals in Europe.

BIO-Europe is scheduled to take place on November 6-8 in Munich, Germany, and digitally on November 14-15.

(June 2023)

Nordic Life Sciences Days, Copenhagen, Denmark, 29-30 November 2023.

Nordic Life Science Days offers a unique opportunity to partner and network with the best of Nordic and international life science leaders. Here, you’ll meet both world-renowned and up-and-coming companies and take a deep dive into the latest trends in the industry through program events and super sessions on stage.

This year, the conference is celebrating its 10th anniversary. To make it extra special, the NLS Days will for the first time be hosted at Bella Arena in Copenhagen, Denmark, on November 29-30.

(June 2023)

Xplico elected a Gazelle Company for the 4th year in a row

We are proud to announce that Xplico has been elected a Gazelle company for the 4th year in a row.

The election is organized by the Danish financial newspaper Børsen, and the requirements to become a Gazelle company are tough. A Gazelle business is continuously growing and, as a minimum, doubles its revenue or gross profit over four fiscal years, while maintaining positive growth throughout the years.

It is quite impressive that we have been able to live up to this four years in a row and we express our gratitude to our customers because without their continuous support and trust this would not have been possible.

(October 2019)

Publication of the Xplico Valuation Survey

In July and August 2018 Xplico conducted a survey among 600 industry professionals about valuation in the life science industry and received 79 responses. We hereby present the results of the survey.
(November 2018)

Xplico article for Biotech & Money / LSX

In an article for Biotech & Money / LSX – The Network For Life Science Executives, our partner, Finn Nikolajsen, gives his point of view on the challenges of the ownership structures that the biotech companies and their investors face when they try to analyze the consequences of current and future funding rounds and exits.

(October 2018)

Xplico article for Biotech & Money / LSX

In an article for Biotech & Money / LSX – The Network For Life Science Executives, our partner, Uffe Boesen, gives his point of view on the challenges that the Nordic life science companies face.

(August 2018)

Xplico Interview with Biotech & Money / LSX

In an interview with Biotech & Money / LSX – The Network For Life Science Executives, our partner, Uffe Boesen, explains how valuation is critical for strategic decision-making and points out to some of the common pitfalls companies encounter when using valuation models that are built in house.

(June 2018)